Vir Biotechnology, Inc. VIR Business Segments — Plus: Other segment items
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:SegmentReportingOtherItemAmount.
The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vir Biotechnology, Inc.'s business segments — plus: other segment items.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vir Biotechnology, Inc.'s business segments — plus: other segment items?
- Vir Biotechnology, Inc. (VIR) reported business segments — plus: other segment items of $6.6M in Q1 2026.
- How has Vir Biotechnology, Inc.'s business segments — plus: other segment items changed year-over-year?
- Vir Biotechnology, Inc.'s business segments — plus: other segment items decreased by 64.5% year-over-year, from $18.58M to $6.6M.
- What is the long-term trend for Vir Biotechnology, Inc.'s business segments — plus: other segment items?
- Over 3 years (2022 to 2025), Vir Biotechnology, Inc.'s business segments — plus: other segment items has grown at a -49.3% compound annual growth rate (CAGR), from $317.23M to $41.34M.
- What does business segments — plus: other segment items mean?
- Includes miscellaneous income or expense items specific to the segment that do not fall into standard operating categories. This metric is used to reconcile segment performance by capturing unique financial events or adjustments relevant to the segment's specific operations.